Correction: Tian et al. Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells. J. Pers. Med. 2022, 12, 1318

By afschroeder • February 27, 2026

Tian S, Su R, Wu K, Zhou X, Vadgama JV, Wu Y. Correction: Tian et al. Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells. J. Pers. Med. 2022, 12, 1318. J Pers Med. 2026 Feb 9;16(2):101. doi: 10.3390/jpm16020101. Erratum for: J Pers Med. 2022 Aug 16;12(8):1318. doi: 10.3390/jpm12081318. PMID: 41745417; PMCID: PMC12941905.

Tags: General Internal Medicine, King Drew Med Ctr, Publications

Evaluating the accuracy of brief cognitive assessments for the early detection of cognitive impairment in adults across primary and specialty care settings: A systematic review and meta-analysis

Loveless J, Pilcher L, Bolton CJ, Guan DX, Imo U, Ngubo CGA, McAteer MB, Urquhart O, Rangarajan SK, Kim LS, Sako K, Tang B, Yakoub[...]

Effect of Electronic Behavioral Nudges on Low-Value Preoperative Testing: A Pragmatic Randomized Clinical Trial

Sarkisian CA, Villaflores CW, Vangala SS, Cheng EM, Shu SB, Goldstein NJ, Hofer IS, Duval VF, Bartlett JD, Moore JM, Pessegueiro AM, Skootsky SA, Damberg[...]

Collaborative Solutions to Identify Scheduling Barriers for Timely Post-Hospital Discharge Primary Care Follow-Up: A Quality Improvement Initiative

Le B, Simon W, Zhang J, Robertson J, Dowling E. Collaborative Solutions to Identify Scheduling Barriers for Timely Post-Hospital Discharge Primary Care Follow-Up: A Quality[...]